Based on 784 businesses audited.
Lupin has 13.7 points more reputation than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech Reputation: Lupin (lupin.com)
Lupin passes the substance test despite a high-fluff marketing veneer on its homepage. The presence of granular ESG data and verifiable US market rankings makes this a low-BS corporate site that uses ‘hope and healing’ as a wrapper for a massive, metrics-driven industrial operation.
Medical Devices, Pharma & Biotech Reputation: Lupin (lupin.com)
The site content perfectly aligns with the Pharmaceutical and Biotech industry, referencing global generics, specialty medications, biosimilars, and R&D facilities. Evidence includes mention of Q1 FY26 financial results, NSE/BSE listings, and specific therapeutic areas like anti-TB, anti-diabetes, respiratory, and cardiology.
“The score of 73 is driven primarily by industry clichés (commodity fingerprint) and heading fluff on the homepage. It was saved from a higher BS score by the high-density sustainability reporting and specific market prescription rankings that prove the 'global leader' signal. The lack of an H1 on the homepage and the use of 'Hope into Healing' marketing tropes prevented a 'Minimal BS' (sub-20) score.”